O’Melveny Worldwide
  • CapsoVision, Inc. (NASDAQ: CV) in its approximately US$27.5 million IPO and listing on NASDAQ
  • Dragonfly Energy Corp., an energy provider and battery producer, in its definitive business combination with a Nasdaq-listed SPAC company, which will make it a public company valued at US$500 million
  • Brii Biosciences Limited in its US$318 million IPO and listing on the Hong Kong Stock Exchange
  • Piper Jaffray & Co., JMP Securities LLC, Raymond James & Associates, Inc. and SunTrust Robinson Humphrey, Inc. as underwriters in a secondary offering of approximately US$64 million in common stock of Nuvectra Corporation, a neurostimulation medical device company
  • Shanghai Haohai Biological (6826.HK) in its US$300 million IPO and listing on the Hong Kong Stock Exchange
  • Bank of Qingdao (03866.HK) in its US$531 million IPO and listing on the Hong Kong Stock Exchange
  • Fidelity, major shareholder of Innovent Biologics, in Innovent Biologics’ US$412 million IPO on the Main Board of the Hong Kong Stock Exchange
  • Pharmaron, an R&D service provider for the life sciences industry, in its proposed Hong Kong IPO
  • Hua Medicine (2552.HK) in its US$110 million Chapter 18A biotech company IPO sponsored by Goldman Sachs and CLSA Limited
  • Lending Club, as underwriters’ counsel, in its US$1 billion IPO
  • WuXi PharmaTech (NYSE: WX) in its US$212 million US IPO

Admissions

Bar Admissions

  • California
  • New York

Education

  • University of Texas, Austin, J.D., 1988: cum laude; Order of the Coif; associate editor, Texas Law Review
  • University of Arizona, Tucson, B.S., Accounting, 1983: with honors, Beta Alpha Psi

Professional Activities

Member

  • American Bar Association

Other

  • Certified Public Accountant

Publications

  • “Accessing Capital Through Customised PIPE Offerings,” Eurekahedge e-newsletter (November 15, 2016)